SCAP and cancer: Notably, a specific inhibitor of SCAP, fatostatin, has been reported to bind to the SCAP protein and block the formation of the SCAP-SREBP complex, which inhibits SREBP activity and subsequently attenuates the expression of lipogenic genes and alters cellular metabolism, thereby controlling cancer cell survival [214].